Hartl Dana M
Department of Head and Neck Oncology, Institut Gustave Roussy, Villejuif, France.
Otolaryngol Clin North Am. 2012 Oct;45(5):1143-61. doi: 10.1016/j.otc.2012.06.014. Epub 2012 Jul 31.
The main issue in the management of glottic squamous cell carcinoma, as for all cancers, is adequate disease control while optimizing functional outcomes and minimizing morbidity. This is true for early-stage disease as for advanced tumors. This article evaluates the current evidence for the diagnostic and pretherapeutic workup for glottic squamous cell carcinoma and the evidence concerning different treatment options for glottic carcinoma, from early-stage to advanced-stage disease.
与所有癌症一样，声门鳞状细胞癌管理中的主要问题是在优化功能结果并将发病率降至最低的同时，实现对疾病的充分控制。对于早期疾病和晚期肿瘤都是如此。本文评估了声门鳞状细胞癌诊断和治疗前检查的现有证据，以及从早期到晚期声门癌不同治疗选择的证据。
